Contact Us

Shanghai Headquarters

334 Aidisheng Rd.,Zhangjiang High-Tech Park,

Shanghai 201203 China
Tel:+86(0)21 6089 3288
Fax:+86(0)21 6089 329

General Contact:

Tel:+1 6304323100 (US)

©Viva Biotech (Shanghai) Ltd. 沪ICP备12042930号   Powerd by 

Company News
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Integration and Escalation of the Service Chain of Innovative Drug Industry
August 8th, 2020, Viva Biotech (Shanghai) Co., Ltd. entered into the Share Purchase Agreement pursuant and the Vendors agreed to collectively sell 80% of the equity interest in Zhejiang Langhua Pharmaceutical Co., Ltd.
ABM Therapeutics has Completed A + Round Financing of 20 Million US Dollars
This round of financing will be used to accelerate the clinical research and development of ABM-1310 and several existing preclinical projects.
Dr. David Xu, Chief Business Officer of Viva Biotech: Innovative drugs must effectively address unmet clinical needs
“New breakthroughs in scientific research do not necessarily solve specific practical problems, but innovative drugs must effectively address clinical needs.”
Viva Biotech Announces Strategic Partnership with Harbour BioMed to Collaborate on Incubating Innovative Biotech Start-ups
Both parties will collate their respective expertise in drug discovery and development to promote the incubation of innovative biotech startups.
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
A strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets.
Page up